Skip to content

Author

Hai-Ying Ji

We have 1 of 13 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

A Nanodelivery Platform Harnessing Synthetic Lethality and Efferocytosis Inhibition for Synergistically Enhanced Immunotherapy of Triple-Negative Breast Cancer.

Findings indicate that precise molecularly targeted ICD combined with coordinated immune activation enables efficient primary tumor suppression and promotes T-cell phenotypes associated with antitumor immune memory, providing a novel paradigm for cancer immunotherapy.

Hua-Wei Liu, Sheng-Ming Wu, Han Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.